Background: Therapies to stabilize clinical manifestations and prolong pregnancies to attain fetal viability in preeclampsia do not exist 1. Antiangiogenic factor, Soluble fms-like tyrosine kinase1 (sFlt-1) induces preeclampsia-like phenotype in experimental models 2 , and circulates at high levels in preeclampsia. Extracorporeal removal of circulating sFlt-1 by Dextran-sulfate apheresis reduces proteinuria and stabilizes blood pressure without apparent adverse effects on fetus and mother 1 .Serum, Urine, and fractional excretion of sFlt-1 are much higher among severe preeclamptic women compared to mild pre-eclamptic controls 3. Consuming plenty oral fluids and producing urine output more than 2500ml/24hrs, may significantly reduce clinical symptoms, and may help to continue pregnancies to viability, as enhanced sFlt1 renal excretion is possible. Methods: In this case control study, twenty women with very preterm (<34wks) preeclampsia with hydration therapy was compared with gestational age matched twenty controls without intervention. Cases were advised to consume plenty oral fluids and produce a targeted urine output more than 2500ml/24hrs. Anti-hypertensive drugs, Nifidepin, T. Labetalol, and weekly Inj. Hydroxy progesterone were given. Mean arterial pressure, urine albumin dipstick, edema grade, serum sodium, and potassium were recorded at different gestational ages in both groups and compared. The number of weeks that pregnancy continued, birth-weights, RDS, NICU admission days, indications for termination of pregnancies, and take home babies, were recorded in both groups and compared. Amniotic Fluid Optical Density estimations (AFOD) were done at the time of termination of pregnancies in cases. Results: Mean daily urine output was 3692±989ml in cases. Statistically significant reduction in blood pressure, albuminuria, edema, was observed in cases (P=0.000, 0.000, 0.000). Continuation of pregnancy in cases was 7.51±5.22wks, and in controls it was 1.38±1.18wks (P=0.000). Significant decrease in RDS, NICU admission days (P=0.000, 0.001), and increase in birth-weights and take home babies (P=0.000, 0.041) were observed in cases. No significant difference was observed in serum sodium, and potassium levels between two groups (P=0.201, 0.072). The Mean AFOD at termination of pregnancies in casas was 0.86±0.37 Conclusion: Oral hydration therapy with urine output 3962±989ml/24hrs helps to prolong very preterm pre-eclamptic pregnancies to term with good perinatal outcome.